Trial Details

COMPLETED
Basic Information
Clinical ID c2128
Identifier NCT03942120
Trial Title Post-Marketing Surveillance for Crohn's Disease Participants Treated With Stelara (Ustekinumab)
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Crohn Disease
Interventions DRUG: Ustekinumab
Participant Information
Sponsor Janssen Korea, Ltd., Korea
City Busan
Country/Region South Korea
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase NULL
Time Information
Start Date 2019-04-08
Primary Completion Date 2022-01-14
Completion Date 2022-01-14